Company profile: Metaphore Bio
1.1 - Company Overview
Company description
- Provider of the MIMIC™ platform, a bioplatform that integrates machine learning and molecular mimicry to engineer therapeutics targeted at specific biological responses.
Products and services
- Biomimicry Therapeutic Engineering: Industrial-grade methodology combining molecular mimicry with machine learning to architect therapeutics precisely aimed at eliciting specific biological responses
- Machine Learning–Molecular Mimicry Integration: AI-driven system fusing machine learning with molecular mimicry to develop therapeutics targeted to achieving specific biological responses
- MIMIC™ Platform: Custom-engineered bioplatform integrating machine learning with molecular mimicry to engineer therapeutics directed at specific biological responses
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Metaphore Bio
Verana Health
HQ: United States
Website
- Description: Provider of research-ready data modules and services to support drug and device development, clinical trials, and commercialization. Offers Qdata spanning ophthalmology, neurology, and urology, including Urology Qdata from the AUA Quality Registry, plus clinical development support, HEOR & medical affairs analyses, and real-world therapy utilization insights for market forecasting and monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Verana Health company profile →
Immunai
HQ: United States
Website
- Description: Provider of immunology mapping and reprogramming solutions leveraging machine learning and software engineering, including AMICA—a comprehensive immune cell knowledge base integrating clinico-genomic data; single-cell analysis and functional genomics; and drug discovery and development support from target discovery and validation through compound validation and clinical trial optimization, with biopharma and academic partnerships contributing data back to AMICA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunai company profile →
Longboat
HQ: Ireland
Website
- Description: Provider of well-designed, practical technology solutions that address investigator site engagement and protocol compliance challenges in global clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Longboat company profile →
Cisiv
HQ: United Kingdom
Website
- Description: Provider of real-world data technology for pharmaceutical companies, including Baseline Plus for late-phase research with customizable workflows; a 21 CFR Part 11-compliant eConsent module integrated with Baseline Plus; patient apps for PROs, COAs, and eDiaries; electronic tools for observational studies; support for post-approval safety studies (PASS); and systems for retrospective chart reviews.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cisiv company profile →
PlanDomino
HQ: Ireland
Website
- Description: Provider of a fully digitised system simplifying management of complex testing laboratories by managing samples, people, instruments, and non-test lab activities, which can offer savings north of 50% at reduced cost and with shorter lead-in time.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PlanDomino company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Metaphore Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Metaphore Bio
2.2 - Growth funds investing in similar companies to Metaphore Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Metaphore Bio
4.2 - Public trading comparable groups for Metaphore Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →